Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications-Reference-Cited by-同舟云学术

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications

Published:2010-01 Issue:1 Volume:94 Page:1-11
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Chi Alexander,Liao Zhongxing,Nguyen Nam P.,Xu Jiahong,Stea Baldassarre,Komaki Ritsuko

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference87 articles.

1. Randomized trial of lobectomy versus limited resection for T1 N0 non-small-cell lung cancer. Lung cancer study group;Ginsberg;Ann Thorac Surg,1995

2. Perez and Brady’s principles and practice of radiation oncology,2007

3. Bronchoalveolar carcinoma: factors affecting survival;Daly;Ann Thorac Surg,1991

4. Incidence of local recurrence and second primary tumors in resected stage I lung cancer;Martini;J Thorac Cardiovasc Surg,1995

5. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma;Nguyen;Cancer Treat Rev,2008

Cited by 304 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equivalent uniform RBE‐weighted dose in eye plaque brachytherapy;Medical Physics;2024-02-14

2. A PET/CT radiomics model for predicting distant metastasis in early-stage non–small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study;Radiation Oncology;2024-01-22

3. Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial;Nature Communications;2023-09-02

4. Radiothérapie stéréotaxique (RTST) pulmonaire des tumeurs de moins de 3 cm (stade I) et 5 cm (stade II) non opérées : 10 ans d’expérience de l’Institut du Cancer de Montpellier (ICM);Cancer/Radiothérapie;2023-09

5. Influence de l’immunothérapie sur le choix du traitement des cancers bronchiques non à petites cellules de stade I : point de vue de l’oncologue radiothérapeute;Cancer/Radiothérapie;2023-09